Nature’s Sunshine Products, Inc. (NASDAQ: NATR) has reported a 9% year-over-year decline in net sales for the third quarter of 2026, with revenue falling to $116.6 million from $128.3 million in the same quarter last year. The results reflect ongoing challenges in the company’s China operations and Digital business.
The herbal and nutritional supplements company announced its financial results for the quarter ended September 30, 2026. Sales declined by 7% after excluding foreign currency effects, showing that the slowdown was not solely related to exchange-rate movements.
Nature’s Sunshine also recorded a significant decline in profitability. Net income attributable to common shareholders dropped to $1.9 million, or $0.11 per diluted share, compared with $5.3 million, or $0.30 per diluted share, in the third quarter of 2025.
Adjusted EBITDA decreased to $11.1 million from $15.2 million, while gross profit margin slipped to 72.9% from 73.3%. Operating income also declined to $5.3 million, compared with $9 million a year earlier.
CEO Ken Romanzi identified China as one of the main factors affecting the company’s quarterly performance. He said operational disruptions had a greater impact on the consultant leadership base than management initially expected.
The company has already started rebuilding its consultant network in China. However, the disruption has affected business performance, making the recovery of its leadership base an important priority.
Nature’s Sunshine also highlighted challenges in its Digital business. Following several quarters of strong growth, the company is continuing to invest in this segment to support its next phase of development.
Romanzi described the third-quarter results as disappointing and below expectations but said management remains confident in the company’s long-term potential. The company’s focus is now on addressing operational difficulties while strengthening its digital operations.
Reflecting the stronger U.S. dollar and ongoing challenges in China, Nature’s Sunshine has lowered its full-year 2026 financial guidance. The company now expects net sales of $460 million to $470 million, compared with its previous forecast of $490 million to $500 million.
Its adjusted EBITDA outlook has also been reduced from 48million–52 million to 44million–48 million. As of September 30, 2026, the company reported $89.4 million in cash and cash equivalents and no debt.
The revised outlook highlights the pressure facing Nature’s Sunshine as it works to rebuild its China consultant network and address challenges in its Digital business. Future results will show whether these efforts can help restore stronger growth.
There are no reviews yet. Be the first one to write one.
